Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study

I-Chieh Mao1 Division of Critical Care, Departmen of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan

Ching-Yeh Lin2 Division of Hematology and Oncology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan

Chia-Lin Wu3 Division of Nephrology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan, [email protected];4 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

Chew-Teng Kor5 Internal Medicine Research Center, Changhua Christian Hospital, Changhua, Taiwan, [email protected];6 Graduate Institute of Statistics and Information Science, National Changhua University of Education, Changhua, Taiwan, [email protected]Correspondence[email protected]

Chia-Chu Chang3 Division of Nephrology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan, [email protected];7 Department of Internal Medicine, Kuang Tien General Hospital, Taichung, Taiwan, [email protected];8 School of Medicine, Chung-Shan Medical University, Taichung, Taiwan, [email protected];9 Department of Nutrition, Hungkuang University, Taichung, Taiwan, [email protected]Correspondence[email protected]

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date